Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Insight & Intelligence™

Back to Item »

FDA’s Hearing for Biosimilars Showcased Issues Ranging From Definitions to Study Requirements to IP

Industry appeared to provide broad support for draft rules but pointed to areas that need tweaking.

Forward this item to a colleague:
Your name
Your email
(Separate multiple addresses by commas)
 
Colleague's email
(Separate multiple addresses by commas)
 
Personal Message
(optional)
 
 
 

GEN Poll

More » Poll Results » Archive »

GEN’s Hall of Shame

Will you be voting for any of the candidates on GEN’s Hall of Shame list in the next election?

Suggest a Poll